A novel Fc-optimized antibody drug conjugate targeting CD7 as a therapeutic strategy in T-cell acute lymphoblastic leukemia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:142 |
|---|---|
| Enthalten in: |
Blood - 142(2023), Supplement 1, Artikel-ID 4190 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gehlert, Carina Lynn [VerfasserIn] |
|---|
| Links: |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1182/blood-2023-185875 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1882960033 |
|---|
| LEADER | 01000naa a2200265 4500 | ||
|---|---|---|---|
| 001 | 1882960033 | ||
| 003 | DE-627 | ||
| 005 | 20240308104756.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240308s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2023-185875 |2 doi | |
| 035 | |a (DE-627)1882960033 | ||
| 035 | |a (DE-599)KXP1882960033 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gehlert, Carina Lynn |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A novel Fc-optimized antibody drug conjugate targeting CD7 as a therapeutic strategy in T-cell acute lymphoblastic leukemia |
| 264 | 1 | |c 2023 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Schewe, Denis Martin |d 1976- |e verfasserin |0 (DE-588)129738549 |0 (DE-627)478573103 |0 (DE-576)297811827 |4 aut | |
| 700 | 1 | |a Klausz, Katja |d 1980- |e verfasserin |0 (DE-588)138243212 |0 (DE-627)600662888 |0 (DE-576)306874555 |4 aut | |
| 700 | 1 | |a Krohn, Steffen |e verfasserin |4 aut | |
| 700 | 1 | |a Winterberg, Dorothee |e verfasserin |4 aut | |
| 700 | 1 | |a Vogiatzi, Fotini |e verfasserin |0 (DE-588)1223005305 |0 (DE-627)1742299881 |4 aut | |
| 700 | 1 | |a Boje, Ammelie |e verfasserin |0 (DE-588)1294997939 |0 (DE-627)185180708X |4 aut | |
| 700 | 1 | |a Lux, Anja |d 1982- |e verfasserin |0 (DE-588)143434128 |0 (DE-627)646099035 |0 (DE-576)337047790 |4 aut | |
| 700 | 1 | |a Nimmerjahn, Falk |d 1972- |e verfasserin |0 (DE-588)123995523 |0 (DE-627)085572519 |0 (DE-576)293974470 |4 aut | |
| 700 | 1 | |a Scherließ, Regina |e verfasserin |0 (DE-588)1164191772 |0 (DE-627)102865409X |0 (DE-576)508429293 |4 aut | |
| 700 | 1 | |a Humpe, Andreas |e verfasserin |0 (DE-588)14124819X |0 (DE-627)625834674 |0 (DE-576)322982529 |4 aut | |
| 700 | 1 | |a Schrappe, Martin |d 1958- |e verfasserin |0 (DE-588)130458805 |0 (DE-627)501601678 |0 (DE-576)298208423 |4 aut | |
| 700 | 1 | |a Cario, Gunnar |d 1972- |e verfasserin |0 (DE-588)122450868 |0 (DE-627)081951167 |0 (DE-576)293277052 |4 aut | |
| 700 | 1 | |a Valerius, Thomas |e verfasserin |0 (DE-588)1012543153 |0 (DE-627)661835510 |0 (DE-576)345576004 |4 aut | |
| 700 | 1 | |a Fransecky, Lars |d 1982- |e verfasserin |0 (DE-588)139238905 |0 (DE-627)60944591X |0 (DE-576)310206634 |4 aut | |
| 700 | 1 | |a Brüggemann, Monika |d 1968- |e verfasserin |0 (DE-588)173026753 |0 (DE-627)697951596 |0 (DE-576)133879666 |4 aut | |
| 700 | 1 | |a Baldus, Claudia |d 1972- |e verfasserin |0 (DE-588)122672631 |0 (DE-627)705995054 |0 (DE-576)293374945 |4 aut | |
| 700 | 1 | |a Gramatzki, Martin |e verfasserin |0 (DE-588)144039818 |0 (DE-627)656824913 |0 (DE-576)340498420 |4 aut | |
| 700 | 1 | |a Lenk, Lennart |e verfasserin |4 aut | |
| 700 | 1 | |a Kellner, Christian |d 1976- |e verfasserin |0 (DE-588)137154259 |0 (DE-627)590341383 |0 (DE-576)302375996 |4 aut | |
| 700 | 1 | |a Peipp, Matthias |d 1969- |e verfasserin |0 (DE-588)129541214 |0 (DE-627)472301853 |0 (DE-576)297713183 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 142(2023), Supplement 1, Artikel-ID 4190 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnns |
| 773 | 1 | 8 | |g volume:142 |g year:2023 |g number:Supplement 1 |g elocationid:4190 |g extent:3 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood-2023-185875 |x Resolving-System |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_178 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_266 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2424 | ||
| 912 | |a GBV_ILN_2446 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 142 |j 2023 |e Supplement 1 |i 4190 |g 3 | ||
| 980 | |2 178 |1 01 |x 3178 |b 4497969118 |y x |z 08-03-24 | ||
| 982 | |2 178 |1 00 |x 3178 |8 00 |0 (DE-627)504386107 |a Universitätskinderklinik <Magdeburg> | ||
| 982 | |2 178 |1 00 |x 3178 |8 01 |a Schewe, Denis Martin / KPAE | ||
| 982 | |2 178 |1 00 |x 3178 |8 02 |0 (DE-627)719906873 |a Abstract | ||
| 983 | |2 178 |1 00 |x 3178 |8 00 |a Impact factor: 20.3 | ||
| 983 | |2 178 |1 01 |x 3178 |8 99 |a j2023 | ||